DDW: Endoscopic Procedure May Eliminate Insulin Use in T2DM

TUESDAY, May 2, 2023 -- Recellularization via electroporation therapy (ReCET) combined with glucagon-like peptide-1 receptor agonist (GLP1-RA) treatment is safe and feasible for type 2 diabetes and can eliminate the use of insulin therapy, according...